Taking a daily aspirin to help prevent a heart attack has been standard advice for just about anybody considered at risk for heart disease. But recently the U.S. Food and Drug Administration (FDA) issued a recommendation that essentially says daily aspirin therapy is only for individuals with diagnosed cardiovascular problems. The FDA argues that research hasnt proven a benefit for people without cardiovascular disease. The report contends that having a risk factor, such as family history of heart disease, isnt enough to risk the potential bleeding problems associated with aspirin use.
To continue reading this article or issue you must be a paid subscriber.
Sign in
